Rockefeller Capital Management L.P. Editas Medicine, Inc. Transaction History

Rockefeller Capital Management L.P.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.36 - $11.47 $2,410 - $4,347	379 Added 2.09%	18,533 $152,000
Q1 2023 May 17, 2023	BUY	$7.03 - $11.53 $7,030 - $11,530	1,000 Added 5.83%	18,154 $131,000
Q4 2022 Mar 06, 2023	SELL	$8.32 - $13.21 $14,684 - $23,315	-1,765 Reduced 9.33%	17,154 $152,000
Q3 2022 Nov 02, 2022	BUY	$12.16 - $19.42 $486 - $776	40 Added 0.21%	18,919 $231,000
Q2 2022 Aug 12, 2022	BUY	$9.99 - $21.35 $22,407 - $47,888	2,243 Added 13.48%	18,879 $223,000
Q1 2022 May 13, 2022	BUY	$14.08 - $27.63 $211,242 - $414,532	15,003 Added 918.74%	16,636 $316,000
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $166,203 - $253,968	-6,260 Reduced 79.31%	1,633 $43,000
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $211,233 - $392,344	5,379 Added 213.96%	7,893 $323,000
Q2 2021 Aug 10, 2021	BUY	$31.29 - $56.64 $14,549 - $26,337	465 Added 22.69%	2,514 $142,000
Q1 2021 May 11, 2021	BUY	$39.71 - $90.58 $40,424 - $92,210	1,018 Added 98.74%	2,049 $86,000
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $12,641 - $39,391	467 Added 82.8%	1,031 $72,000
Q3 2020 Nov 13, 2020	BUY	$28.06 - $37.16 $15,825 - $20,958	564 New	564 $15,000
Q1 2020 May 12, 2020	SELL	$14.88 - $32.78 $104 - $229	-7 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$19.49 - $32.63 $136 - $228	7 New	7 $0

227

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $118M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.